Puregraft

What Puregraft does

Puregraft is a medical device company that develops and commercializes systems for processing and transferring adipose (fat) tissue in aesthetic and reconstructive surgical procedures. Founded in 2013 and headquartered in Solana Beach, California, the company operates today as a product line under Bimini Health Tech. Its core offering is the Puregraft system, a device used by surgeons to harvest, purify, and transplant autologous fat, complemented by the Dermapose product line targeting similar fat grafting applications. The devices address a clinically demanding use case — safe and reproducible fat grafting for breast reconstruction, facial augmentation, body contouring, and related procedures — where processing quality directly affects graft survival rates and patient outcomes.

The company serves board-certified plastic and reconstructive surgeons as well as ambulatory aesthetic surgery centers. Its end customers are technically specialized practitioners who prioritize regulatory-cleared, sterile, and reproducible tissue processing over generic alternatives. Puregraft does not sell consumables through a direct sales force; instead it operates as a focused product brand within the broader Bimini Health Tech portfolio, with go-to-market executed through international healthcare distribution partners. The product line is commercially available in over 50 countries — including the United States, European Union, Japan, Brazil, Australia, Canada, and Saudi Arabia — and is sold under a one-time purchase revenue model rather than a recurring or procedure-based pricing structure.

On May 13, 2026, parent company Bimini Health Tech announced EU Medical Device Regulation (MDR) certification for both the Puregraft and Dermapose product lines, a regulatory milestone that opens market access across all 27 EU member states and the broader EEA. The company explicitly framed the certification as a vehicle to capture share of the global fat transfer market, which — citing ISAPS data — exceeded 940,000 procedures annually and grew 19.2% year-over-year. Puregraft's overall organizational footprint remains small (1-10 employees reported), consistent with a product-line operating model where manufacturing, distribution, regulatory affairs, and commercial scale-up are absorbed into the parent Bimini Health Tech structure.

Name

Puregraft

Website

https://puregraft.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Puregraft develops and commercializes medical devices for adipose tissue processing and fat transfer in aesthetic and reconstructive surgery, serving plastic surgeons and ambulatory surgery centers across more than 50 countries as a product line of Bimini Health Tech.

Ownership category

akta.pro rank

Product category

Medical Devices for Fat Transfer

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)

Keywords

• Fat transfer devices
• Adipose tissue processing
• Aesthetic surgery devices
• Reconstructive surgery products
• Medical device distribution

Headquarters

HQ city

Solana Beach

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel

Revenue model

1. Medical Device Sales: Revenue generated from the sale of fat transfer medical devices and related products to healthcare providers and surgical centers

Go-to-market motion1 record

Distribution channels1 record

Core offering

Puregraft is a medical device product line specializing in fat transfer technology for aesthetic and reconstructive surgical procedures. The portfolio includes the Puregraft and Dermapose systems designed for processing and transplanting adipose tissue, serving plastic surgeons and aesthetic surgery centers in over 50 countries.

Product overview

Puregraft operates as a product portfolio under Bimini Health Tech, consisting of specialized fat transfer product lines including Puregraft and Dermapose. These products are designed for adipose tissue processing and transfer in aesthetic and reconstructive surgical procedures. Both product families serve the fat transfer market, which saw over 940,000 procedures performed worldwide according to ISAPS data, representing 19.2% year-over-year growth.

Differentiator

Problem solved

Functional benefit

Products and services

• Puregraft Fat transfer product line for aesthetic and reconstructive procedures, designed for processing and transferring adipose tissue. Available in over 50 countries worldwide for plastic and reconstructive surgeons.
• Dermapose Fat transfer product line cleared for use in the EU, US, Japan, Brazil, Australia, Canada, and Saudi Arabia for aesthetic and reconstructive applications.

Quantifiable outcome

• 19.2% year-over-year growth in fat transfer procedures worldwide

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Bimini Health TechcoreStrategic or Co-development Partner · 13 May 2026Puregraft is a product line owned by Bimini Health Tech. The parent company announced EU MDR certification for Puregraft and Dermapose fat transfer product lines, marking a significant milestone in global expansion efforts. Bimini Health Tech aims to capture significant share of the growing fat transfer market.

Scale indicators2 records

Recent moves3 records

Expansion highlights4 records

Emerging players

• Sterimedix: UK-based manufacturer of single-use surgical instruments including cannulas used in fat transfer. Partial overlap with Puregraft's single-use device approach but broader portfolio.

Broad incumbents

• Mentor (Johnson & Johnson MedTech): A Johnson & Johnson company producing breast implants and related reconstructive surgery products. Serves the same plastic surgeon customer base as Puregraft and operates broadly in aesthetic/reconstructive surgery.
• Allergan Aesthetics (AbbVie): Major aesthetics incumbent under AbbVie offering breast implants, fillers, and surgical products. Overlaps with Puregraft's reconstructive and aesthetic surgery customers but is not specialized in fat transfer.

Direct peers

• Tulip Medical Products: Manufactures fat transfer cannulas, syringes, and harvesting/transfer kits for plastic surgeons. Directly competes with Puregraft in single-use fat grafting instrumentation.
• Lipocube: Develops closed-system fat transfer devices and microfat/nanofat processing kits. Direct competitor to Puregraft in adipose tissue processing for aesthetic and regenerative procedures.
• Human Med: German medical device company specializing in water-jet assisted liposuction and fat transfer systems (e.g., Body-Jet). Direct competitor to Puregraft in the fat harvesting and transfer device category, serving plastic surgeons globally.
• Cytori Therapeutics: Developed Celution systems for processing adipose tissue into regenerative cell therapies. Directly comparable to Puregraft in adipose tissue processing technology for clinical applications.
• Wells Johnson Company: Manufacturer of power-assisted liposuction equipment with fat transfer applications. Competes with Puregraft in the fat harvesting and grafting device market serving aesthetic surgeons.
• MicroAire Surgical Instruments: Manufactures liposuction and fat harvesting equipment used by plastic surgeons. Overlaps with Puregraft's customer base and procedural use cases in fat transfer workflows.

Others

• Black Tie Medical (MTF Biologics): Tissue and regenerative medicine organization serving reconstructive surgeons with allograft and adipose-derived products. Adjacent ecosystem participant serving overlapping plastic surgery customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/puregraft
• LinkedInlinkedin.com/company/puregraft-llc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Puregraft